Citigroup’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-87,000
| Closed | -$11.4M | – | 5731 |
|
|
2020
Q4 | $11.4M | Buy |
87,000
+84,103
| +2,903% | +$11.1M | 0.01% | 892 |
|
|
2020
Q3 | $146K | Sell |
2,897
-106,444
| -97% | -$5.36M | ﹤0.01% | 2937 |
|
|
2020
Q2 | $5.21M | Buy |
109,341
+103,709
| +1,841% | +$4.94M | ﹤0.01% | 1063 |
|
|
2020
Q1 | $276K | Sell |
5,632
-10,058
| -64% | -$493K | ﹤0.01% | 2668 |
|
|
2019
Q4 | $900K | Buy |
15,690
+13,880
| +767% | +$796K | ﹤0.01% | 2258 |
|
|
2019
Q3 | $65K | Sell |
1,810
-2,626
| -59% | -$94.3K | ﹤0.01% | 3653 |
|
|
2019
Q2 | $138K | Sell |
4,436
-437
| -9% | -$13.6K | ﹤0.01% | 3425 |
|
|
2019
Q1 | $114K | Buy |
4,873
+3,537
| +265% | +$82.7K | ﹤0.01% | 3488 |
|
|
2018
Q4 | $18K | Sell |
1,336
-692
| -34% | -$9.32K | ﹤0.01% | 4461 |
|
|
2018
Q3 | $20K | Buy |
+2,028
| New | +$20K | ﹤0.01% | 4518 |
|